Therapeutic Solutions International, Inc.

OTCPK:TSOI Stock Report

Market Cap: US$4.3m

Therapeutic Solutions International Management

Management criteria checks 4/4

Therapeutic Solutions International's CEO is Tim Dixon, appointed in Mar 2011, has a tenure of 13.67 years. total yearly compensation is $365.00K, comprised of 65.8% salary and 34.2% bonuses, including company stock and options. directly owns 10.99% of the company’s shares, worth $473.12K. The average tenure of the management team and the board of directors is 5.8 years and 6.5 years respectively.

Key information

Tim Dixon

Chief executive officer

US$365.0k

Total compensation

CEO salary percentage65.8%
CEO tenure13.7yrs
CEO ownership11.0%
Management average tenure5.8yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tim Dixon's remuneration changed compared to Therapeutic Solutions International's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$2m

Mar 31 2024n/an/a

-US$2m

Dec 31 2023US$365kUS$240k

-US$2m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$3m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022US$381kUS$240k

-US$4m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$4m

Mar 31 2022n/an/a

-US$3m

Dec 31 2021US$595kUS$227k

-US$3m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$2m

Dec 31 2020US$607kUS$196k

-US$2m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$1m

Dec 31 2019US$286kUS$146k

-US$2m

Sep 30 2019n/an/a

-US$2m

Jun 30 2019n/an/a

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018US$281kUS$174k

-US$2m

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$1m

Mar 31 2018n/an/a

-US$1m

Dec 31 2017US$165kUS$165k

-US$995k

Compensation vs Market: Tim's total compensation ($USD365.00K) is below average for companies of similar size in the US market ($USD655.65K).

Compensation vs Earnings: Tim's compensation has been consistent with company performance over the past year.

CEO

Tim Dixon (66 yo)

13.7yrs

Tenure

US$365,000

Compensation

Mr. Timothy George Dixon, also known as Tim, has been the Chairman and President of MolecuVax, Inc. since 2015. Mr. Dixon has been the Chief Executive Officer, President and Chairman of Therapeutic Solutio...

Leadership Team

NamePositionTenureCompensationOwnership
Timothy Dixon
Chairman13.7yrsUS$365.00k10.99%
$ 473.1k
Feng Lin
Chief Scientific Officer5.2yrsUS$15.00k1.21%
$ 52.1k
James Veltmeyer
Chief Medical Officer6.4yrsUS$75.00k0.72%
$ 31.1k
Famela Ramos
Vice President of Business Developmentno dataUS$15.10k0.12%
$ 5.0k
Serena Robella
Director of Sales4.1yrsno datano data

5.8yrs

Average Tenure

55.5yo

Average Age

Experienced Management: TSOI's management team is seasoned and experienced (5.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Timothy Dixon
Chairman13.7yrsUS$365.00k10.99%
$ 473.1k
James Veltmeyer
Chief Medical Officer6.8yrsUS$75.00k0.72%
$ 31.1k
Howard Leonhardt
Member of Scientific Advisory Board4.8yrsno datano data
Thomas Ichim
Director8.8yrsno data4.04%
$ 173.9k
Pablo Guzman
Member of Scientific Advisory Boardno datano datano data
Francesco Marincola
Member of Scientific Advisory Board6.3yrsno datano data
J. Mizer
Member of Scientific Advisory Board4.1yrsno datano data
Barry Glassman
Chairman of Scientific Advisory Board11.4yrsno datano data
Boris Minev
Member of Scientific Advisory Board3.8yrsno datano data
Santosh Kesari
Member of Scientific Advisory Board9.1yrsno datano data
Nassir Azimi
Member of Scientific Advisory Board6.5yrsno datano data
Juergen Winkler
Member of Scientific Advisory Board6.3yrsno datano data

6.5yrs

Average Tenure

61.5yo

Average Age

Experienced Board: TSOI's board of directors are considered experienced (6.5 years average tenure).